Infective endocarditis (IE) is a serious disease associated with significant morbidity 68 and mortality (1) (2) (3) , whose prognosis strongly depends on early diagnosis and 69 optimized antibiotic therapy. Therefore, identifying the underlying pathogens 70 responsible for IE is critical. Currently, blood and valve cultures are the gold standard 71 for IE pathogens detection, but they are time-consuming and infeasible for fastidious 72 or intracellular microorganisms(4), which is a major clinical problem. Although 73 targeted amplicon sequencing such as 16S rRNA sequencing overcomes the 74 limitations of conventional culture-based methods, it can only be used to screen for 75 bacteria(5,6) and does not provide any antibiotic susceptibility information. 76
Rapid advancements in sequencing technologies provide us with new tools for 77 microbial identification without the need for culturing(7-9). The feasibility of direct 78 pathogens identification from IE samples by short-read whole-genome sequencing on 79 next-generation sequencing (NGS) platforms has been demonstrated in several 80 studies(10,11). Recently, an increased number of studies have shown promise for 81 metagenomics analysis using nanopore long-read sequencing in the rapid detection of 82 microorganisms in clinical samples, including virus from blood samples and bacteria 83 from urine samples(12-14) 84
To evaluate the analytical and clinical sensitivity and specificity of metagenomics 85 analysis in IE diagnosis, we analyzed the sequencing results generated from both 86 NGS and nanopore sequencing in this study. Sequencing platform-specific 87 bioinformatics pipelines were designed and developed in-house to identify pathogens 88 and detect antimicrobial resistance (AMR) in seven culture-negative IE patients. 89 90
Materials and Methods 91

Sample collection and information 92
The resected valves were collected from the Center of Cardiac Surgery in Fuwai 93
Hospital, National Center for Cardiovascular Diseases (Beijing, China), from April 94 2017 to August 2017. The study was approved by the ethics committee of the hospital. 95
All patients involved in this study provided their written informed consent, and 96 samples were used for research only. In our study, we included seven patients (six 97 men and one woman, Table S1 ). These patients were all diagnosed with definite IE 98 (D.IE) according to the modified Duke criteria. The specimens were cut into two 99 equal-sized pieces using sterile scissors in a biosafety cabinet. One piece of tissue was 100 randomly selected for immediate culturing, while the other was snap-frozen at ˗80C 101 for metagenomic sequencing and Sanger validation. 102
Valve culture (VC) and blood culture (BC) 103
The specimens were physically ground into particles using a sterile grinder, then 104 placed in sterile tubes containing 5 ml of brain-heart infusion broth and incubated in a 105 CO 2 enriched atmosphere (5%) at 35C for 7 days. Growth was evaluated daily. After 106 7 days of incubation, all samples were subcultured onto blood agar plates (Oxoid, 107
Beijing, China), chocolate agar plates (Oxoid) and MacConkey agar plates (Oxoid), 108 regardless of whether or not growth was suspected. An average of three sets of blood 109 samples were drawn by peripheral venous puncture prior to antibiotic use. Blood 110 samples (about 10 ml for adults, 1-3 ml for children) were injected into aerobic and 111 anaerobic blood culture bottles (Becton Dickinson, Sparks, MD, USA). Blood culture 112 bottles were then loaded into an automated continuous monitoring system (BD 113 BACTEC TM FX400, USA) within 1 h of being drawn and were incubated at 35C for 114 7 days. If the subculture of the blood or valves showed bacterial growth, identification 115 was carried out by VITEK MALDI-TOF mass spectrometry (bioMérieux, Marcy 116 l'Étoile, France) and antibiotic susceptibility testing was performed subsequently with 117 VITEK 2 COMPACT (bioMérieux). 118
DNA extraction and NGS with BGISEQ-500 119
The frozen valves were thawed at room temperature for 30 min and were then cut into 120 pieces as small as possible with sterile scissors. Approximately 25 mg of tissue was 121 treated with proteinase K (No.148012595, Qiagen, Hilden, Germany) before DNA 122 extraction. Total DNA was extracted using a TIANamp Micro DNA kit (DP316,  123 Tiangen Biotech, Beijing, China) according to the manufacturer's recommendation. 124
The extracted DNA was fragmented with a Bioruptor (ThermoFisher Scientific, 125
Waltham, MA, USA) instrument to generate 200-300 bp fragments. Libraries were 126 then prepared as follows: first, the DNA fragments were subjected to end-repair and 127 A-tailing; second, the resulting DNA was ligated with bubble-adapters that contained 128 a barcode sequence, and then amplified with PCR. Quality control was carried out 129 with an Agilent 2100 (Agilent Technologies, Santa Clara, CA, USA) to assess the 130 fragment size and using a Qubit dsDNA HS Assay kit (ThermoFisher Scientific) to 131 measure the DNA library concentrations. Qualified libraries were pooled together to 132 form single-stranded DNA (ssDNA) circles and then DNA nanoballs were generated 133 with rolling circle replication. The final DNA nanoballs were loaded onto a 134 sequencing chip and were sequenced with a BGISEQ-500 platform (BGI-Tianjin). 135
Human sequence data were excluded by mapping to a human reference (hg19) using 136 the Burrows-Wheeler alignment tool. After removing human sequences, the 137 remaining sequencing data were aligned to four microbial genome databases, 138 consisting of viruses, bacteria, fungi and parasites. The mapped data were processed 139 for advanced data analysis. We downloaded the latest version of the microbial 140 reference genomes from NCBI (ftp://ftp.ncbi.nlm.nih.gov/genomes/ 
MinION library preparation and sequencing 159
The frozen valves were thawed at room temperature for 30 min and were then cut into 160 pieces as small as possible with sterile scissors. Approximately 25 mg of tissue was 161 treated with proteinase K before DNA extraction. Total DNA was extracted using 162 From the pair-end 150 bp sequence data generated from the BGI platform, 183 low-quality reads, adapter contamination, and duplicated reads and short reads (length 184 <35 bp) were removed. The remaining sequences were then used in further analysis. 185
For the sequencing data obtained from the Nanopore MinION sequencer, base-calling 186 tools in Albacore were used to base-call the data in fast5 files and de-multiplex the 187 data to fastq files for each sample. After quality control analysis, reads with lengths 188 longer than 500 bp and mean quality scores >6 were used in further analysis. 189 After species identification, reads that could not be mapped in the human genome 212 were used for AMR analysis. Species identification tags were added and reads were 213 aligned in the AMR database CARD(17)by Blastn. For all query results, hits with 214 blast e-values <e ˗30 were picked for further analysis. For AMR gene tracking, when 215 sequences were aligned, if hits were lacking in the 5ʹ or 3ʹ regions of the gene but 216 coverage of the central part of the gene was observed that would be sufficient to be 217 reported as an AMR gene. For the nanopore data, because of the long read lengths, 218 support from one read was acceptable, but support from three reads was needed for 219 the NGS data. For AMR SNP sites, the coverage level for the gene in which the SNP 220 was located was required to be the same as that from which the AMR gene was 221 detected. Furthermore, each SNP site required support from more than two reads for 222 the nanopore data and three reads for the NGS data. After data had been obtained for 223 AMR genes and SNP sites, the results were organized by drug resistance type using 224 the annotation in the CARD database. Finally, species identification tags were used to 225 map AMR genes to the species level. 226
Species identification of pathogens in seven clinical samples using NGS data and
227
Results 228
Clinical characteristics and diagnosis of seven IE patients 229
To assess the feasibility of metagenomic analysis in the identification of IE pathogens, 230 seven IE patients were included in this study, with most of these patients being male 231 (n=6, 85.7%) with a mean age of 48.3 (Table S2 ). Our strategy was to employ NGS 232 and nanopore sequencing-based metagenomics analysis to identify IE pathogens with 233 verification provided by Sanger sequencing and traditional clinical diagnosis methods 234 (Fig 1 and Fig 2) . 235
The patients were firstly scheduled for systemic examinations in the hospital and all 236 were clinically diagnosed as definite cases of IE according to the modified Duke 237 criteria (Fig 1 and Table 1 ). Most of the blood culture results were negative (n=5) 238 except for Streptococcus oralis detected in patient A5 and Streptococcus anginosus 239 detected in patient A7 (Table 1) . Valve replacement surgeries were then performed 240 and the resected valves were used for Gram-staining and culturing. All of the valve 241 culture results were negative except for one, which was considered to be due to 242 contamination ( Table 1) . 243 Streptococcus sanguinis for A6, and 45,880 reads of S. anginosus for A7) ( Table 2) . 260
NGS-based metagenomic analysis for the detection of IE pathogens 244
Other information such as pathogen coverage and the depth of the NGS sequencing 261 data were also analyzed ( Fig 3A, S1A, and Table 2 ). Because the AMR profile of an 262 IE pathogens provides valuable information that can guide treatment, a specific 263 bioinformatics pipeline was developed to detect the AMR genes present in these 264 bacteria (Fig 2 and Table 3, S3 ). 265
Nanopore sequencing-based metagenomic analysis for IE pathogens detection 266
To evaluate the application of nanopore sequencing-based metagenomics analysis in 267 IE pathogens detection, DNAs from the seven resected valves were sequenced using 268 the MinION system. In brief, 1.2 μg of genomic DNA from each sample was 269 fragmented with g-TUBE and a library was prepared using the Ligation Sequencing 270
Kit and the Native Barcoding Kit (see details in the Materials and Methods section). 271
The sequencing data generated by the MinION system had a quality score of around 272
15. This quality score can be influenced by the quality of DNA samples multiplexed 273 in the same flow cell, and high quality multiplexed DNA samples generate larger data 274 with a higher quality score. For every sequencing read, the quality of the first 10 bases 275 can be unstable, with all subsequent bases having a consistent quality score, even for 276 the end bases of an ultra-long read. Reads longer than 1 kb with an average quality 277 score >7, were used in further bioinformatic analyses (see details in the Materials and 278
Methods section). 279
As a result of metagenomic analysis of the nanopore data, reads of the same IE 280 pathogens were also detected for all samples with NGS (23 and 16 reads of S. 281 gordonii for A1.1 and A1.2, 13 and 23 reads of S. oralis for A2.1 and A2.2, 68 reads 282 of C. burnetii for A3, 2,081 reads of B. quintana for A4, 302 reads of S. oralis for A5, 283 42 reads of S. sanguinis for A6, and 3,302 reads of S. anginosus for A7) (Table 4) . 284
Other information such as pathogen coverage, depth, and read length of the nanopore 285 sequencing data were also analyzed (Fig 3B, S1B, and Table S4 ) with AMR genes of 286 these pathogens detected by the specific bioinformatics pipeline (Fig 2 and Table 3 , 287 S3). 288
As a real-time sequencing platform, data produced by the MinION system can be 289 base-called and analyzed along with sequencing data. Data generation was rapid 290 during the initiation of sequencing, but decreased with time. After 10 h, negative 291 growth of data was noted. The real-time sequencing properties of the MinION device 292 enabled real-time analysis of pathogens detection, and the minimum stable detection 293 time for a pathogen could be altered by using different detection parameters. For 294 example, if the reads detection cutoff was set at two reads, pathogens in all samples 295 could be detected within 1 h (Fig 4 and Table S5 ). 296 In this work, we employed both NGS and Oxford Nanopore Technologies MinION 306 nanopore sequencing for pathogens and AMR detection in seven culture-negative IE 307 patients. Our results showed that both methods can reliably identify the causative 308 pathogen in all seven samples in accordance with the results of Sanger sequencing, 309
with the exception of one case in which Sanger sequencing failed (Table 1) . Moreover, 310 in the case A2 and A5, Sanger sequencing could only identify bacteria to the genus 311 level whereas NGS and nanopore sequencing-based metagenomics analysis could 312 further classify bacteria to the species level. 313
Both the NGS and nanopore sequencing results were in agreement in terms of the top 314 enriched species across all samples; however, the remaining species identified were 315 not concordant between the two methods. The NGS results identified a significantly 316 higher number of different bacteria in each sample (Tables S6 and S7 ). The difference 317 in the amount of sequencing data generated from these two sequencing platforms 318 might contribute to this observation, with a total of 46 Gb of data generated by BGI 319 and only 15 Gb of data generated by MinION for all seven IE samples. Many species 320 identified using the NGS short-reads were of the same genus (Table S6 ). For example, 321 all nine species detected in A1 belonged to the genus Streptococcus, and all 11 322 species in A2 also belonged to Streptococcus. Therefore, we concluded that the 323 long-reads generated by nanopore sequencing increased the specificity of species 324 identification, whereas short-reads generated by NGS had lower resolution within 325 highly homologous species. 326
For AMR analysis, the extensiveness of pathogen genome coverage was critical. 327 AMR-related genes accounted for only about 1% of the bacterial genome, so broader 328 coverage meant a higher chance of detection. The BGI NGS platform had a much 329 higher data output than the MinION system, resulting in more comprehensive 330 pathogen genome coverage. Therefore, more AMR features were detected using NGS 331 sequencing compared with nanopore sequencing in our study. In terms of the AMR 332 genes detected by both platforms, the NGS results were supported by a significantly 333 higher depth of coverage, which improved the confidence associated with the 334 conclusions drawn from these data. However, the short-reads generated by NGS 335 limited the ability to deduce the origin of AMR genes, i.e. it was not possible to 336 determine the identity of the bacteria carrying a particular AMR feature. If a 337 comparable amount of data can be generated on the nanopore sequencing platform, it 338 offers the advantage of long-reads, which would aid the detection of AMR gene 339 origins. One challenge of AMR detection is to tag the AMR genes to specific microbe 340 because of the high homology of one AMR gene from different species. Sequencing 341 method with longer reads and bigger data volume will favor this goal. In most 342 culture-negative cases, clinicians may have to rely on trial and error during treatment, 343 whereas metagenomic methods can provide pathogens and AMR information, helping 344 to guide clinical drug usage. However, it may be necessary to construct clinic-specific 345 AMR libraries to aid the detection of AMR features. 346 A few other challenges were observed when analyzing nanopore sequencing data. 347
Sample barcoding is a common practice during library preparation to improve 348 sequencing cost effectiveness by multiplexing samples on one sequencing run. For 349 example, in this study, we multiplexed 3-6 samples for sequencing. Barcode leaking 350 occurred during de-multiplexing when a barcode was misidentified due to a 351 sequencing error. Although barcode leaking is a common problem shared by both 352 NGS and nanopore sequencing platforms, it was much more apparent in the nanopore 353 sequencing results due to its lower sequencing accuracy (advertised base call accuracy 354 of 99.9% for NGS versus 93% for nanopore 1D sequencing). Therefore, to eliminate 355 the possibility of sample cross-contamination on the nanopore sequencing platform, 356 sample multiplexing is not recommended, especially when analyzing clinical samples. Another major challenge in the metagenomic analysis of clinical samples is the high 361 percentage of host genome. More than 95% of sequencing data mapped to the host 362 (human) genome in most IE samples (Table S8) , which translates to a huge waste of 363 sequencing data; only approximately 5% of the total sequencing data is actually 364 useable in pathogens identification and AMR detection. Development of appropriate 365 host depletion methods before library preparation will be critical to resolve this 366 problem and increase the percentage of useful sequencing data while maintaining the 367 same amount of total sequencing output, thereby improving detection sensitivity. 368
In conclusion, the advantages of NGS included low cost, large data volume, and high 369 accuracy rate. In metagenomic analysis, a higher sequencing output correlated with 370 increased sensitivity in pathogens identification and increased confidence in AMR 371 detection. However, the short read-length of NGS was a limiting factor for species are the cutoff for pathogen detection, corresponding for difference strict level as 528 two reads, five reads and ten reads. When set two reads as the detection cutoff, all 529 pathogens in samples will be detected within 1 h. Even use a higer cutoff (five 530 reads), all pathogens in samples will be detected within 4 h. 531
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